513 related articles for article (PubMed ID: 11929321)
21. Different angiotensin-converting enzyme inhibitors have similar clinical efficacy after myocardial infarction.
Hansen ML; Gislason GH; Køber L; Schramm TK; Folke F; Buch P; Abildstrom SZ; Madsen M; Rasmussen S; Torp-Pedersen C
Br J Clin Pharmacol; 2008 Feb; 65(2):217-23. PubMed ID: 17711535
[TBL] [Abstract][Full Text] [Related]
22. Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure.
Pilote L; Abrahamowicz M; Eisenberg M; Humphries K; Behlouli H; Tu JV
CMAJ; 2008 May; 178(10):1303-11. PubMed ID: 18458262
[TBL] [Abstract][Full Text] [Related]
23. Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors.
Moulder JE; Cohen EP; Fish BL
Int J Radiat Biol; 2014 Sep; 90(9):762-8. PubMed ID: 24991882
[TBL] [Abstract][Full Text] [Related]
24. Comparative pharmacokinetics of captopril, enalapril, and quinapril.
Vertes V; Haynie R
Am J Cardiol; 1992 Apr; 69(10):8C-16C. PubMed ID: 1546641
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin-converting enzyme inhibitors: a comparative review.
Raia JJ; Barone JA; Byerly WG; Lacy CR
DICP; 1990 May; 24(5):506-25. PubMed ID: 2188439
[TBL] [Abstract][Full Text] [Related]
26. Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors?
Ding PY; Hu OY; Pool PE; Liao W
J Hum Hypertens; 2000 Mar; 14(3):163-70. PubMed ID: 10694829
[TBL] [Abstract][Full Text] [Related]
27. Using ACE inhibitors appropriately.
Bicket DP
Am Fam Physician; 2002 Aug; 66(3):461-8. PubMed ID: 12182524
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin-converting-enzyme inhibition in heart failure or after myocardial infarction.
White CM
Am J Health Syst Pharm; 2000 Oct; 57 Suppl 1():S18-25. PubMed ID: 11030019
[TBL] [Abstract][Full Text] [Related]
29. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
[TBL] [Abstract][Full Text] [Related]
30. Critical assessment of ACE inhibitors. Part 2.
Howes LG
Aust Fam Physician; 1995 Apr; 24(4):639, 641-3. PubMed ID: 7771972
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic drug interactions with ACE inhibitors.
Shionoiri H
Clin Pharmacokinet; 1993 Jul; 25(1):20-58. PubMed ID: 8354016
[TBL] [Abstract][Full Text] [Related]
32. Different Angiotensin-converting enzyme inhibitors and the associations with overall and cause-specific mortalities in patients with hypertension.
Chang CH; Lin JW; Caffrey JL; Wu LC; Lai MS
Am J Hypertens; 2015 Jun; 28(6):823-30. PubMed ID: 25498540
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of spirapril in mild-to-moderate hypertension.
Hayduk K; Kraul H
J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 1():S19-23. PubMed ID: 10499560
[TBL] [Abstract][Full Text] [Related]
34. A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors.
Cressman AM; Macdonald EM; Fernandes KA; Gomes T; Paterson JM; Mamdani MM; Juurlink DN;
Br J Clin Pharmacol; 2015 Oct; 80(4):662-9. PubMed ID: 25980448
[TBL] [Abstract][Full Text] [Related]
35. ACE Inhibition with moexipril: a review of potential effects beyond blood pressure control.
Pines A; Fisman EZ
Am J Cardiovasc Drugs; 2003; 3(5):351-60. PubMed ID: 14728069
[TBL] [Abstract][Full Text] [Related]
36. Imidapril in heart failure.
Dolezal T
J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):146-54. PubMed ID: 17094051
[TBL] [Abstract][Full Text] [Related]
37. Spirapril. A preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension.
Noble S; Sorkin EM
Drugs; 1995 May; 49(5):750-66. PubMed ID: 7601014
[TBL] [Abstract][Full Text] [Related]
38. [Preventive therapy with ACE inhibitors for coronary patients].
Keltai M
Orv Hetil; 2004 Feb; 145(9):461-5. PubMed ID: 15077477
[TBL] [Abstract][Full Text] [Related]
39. The problem of underdosing of angiotensin-converting enzyme inhibitors is markedly overrated: results from a study of patients discharged from hospital after an acute myocardial infarction.
Kvan E; Reikvam A;
Eur J Clin Pharmacol; 2004 May; 60(3):205-10. PubMed ID: 15034703
[TBL] [Abstract][Full Text] [Related]
40. Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
Lin CJ; Akarawut W; Smith DE
Pharm Res; 1999 May; 16(5):609-15. PubMed ID: 10350000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
